These aren't GLP-1 agonists that suppress appetite or block nutrient absorption
By Patricia Van Arnum, Editorial Director, DCAT, [email protected] Tariffs: the story of the year Tariff/trade policy in the US has been the story of the year as the US government moved forward with plans to impose reciprocal tariffs or country-by-country tariffs as well as laying the groundwork for possible pharmaceutical industry-specific tariffs and the tariff situation continues to loom large
Given these benefits, it is imperative that we continue exploring their broader therapeutic potential beyond glucose lowering. At the studys conclusion, Wu and his team found that study participants taking GLP-1 agonists had a significantly lower cumulative risk of developing dementia namely, 10% with an incidence of about 2.5%
Collagen and Elastin Synthesis: GHK-Cu and BPC-157 both upregulate collagen and elastin production, improving tissue elasticity, structural strength, and aesthetic recovery following injury or stress 1,3
Your body can then make the most efficient use of these compounds possible
